Improved Automatic Segmentation of White Matter Hyperintensities in MRI Based on Multilevel Lesion Features

M Rincón1, E Díaz-López2, P Selnes3

  • 1Department of Artificial Intelligence, UNED, Madrid, Spain. mrincon@dia.uned.es.

Neuroinformatics
|April 6, 2017
PubMed

Insights

This study introduces AMOS-2D, a new method for segmenting white matter hyperintensities (WMHs) in brain MRI scans. The approach accurately identifies WMHs, matching expert performance across various lesion loads.

Area of Science:

  • Neuroimaging
  • Medical Image Analysis
  • Computational Neuroscience

Background:

  • Brain white matter hyperintensities (WMHs) are crucial indicators of cerebrovascular and neurodegenerative diseases in the elderly.
  • Accurate detection and characterization of WMHs are vital for clinical assessment and disease management.

Purpose of the Study:

  • To develop and evaluate a novel, automated approach for segmenting white matter hyperintensities (WMHs) from multi-contrast MRI data.
  • To improve segmentation performance using both voxel-based and lesion-based information for enhanced accuracy in volume and object metrics.

Main Methods:

  • The proposed AMOS-2D method employs a four-stage "generate-and-test" strategy: pre-processing, Gaussian white matter (WM) modeling, hierarchical multi-threshold WMH segmentation, and support vector machine-based object filtering.
  • Utilized volumetric T1-weighted and 2D FLAIR MRI sequences from 28 subjects with diverse WMH loads.
  • Expert-defined manual lesion masks served as the ground truth for training and validation.

Main Results:

  • The AMOS-2D method achieved performance comparable to inter-expert agreement for both WMH number (Dice Similarity Coefficient [DSC] = 0.637) and volume (DSC = 0.743).
  • Demonstrated superior accuracy in WMH detection compared to alternative methods.
  • Exhibited consistent performance across a wide range of WMH lesion burdens, indicating robustness.

Conclusions:

  • The AMOS-2D approach provides a valuable tool for fully automated WMH segmentation in clinical settings.
  • Its high agreement with expert annotations and stability across varying lesion loads support its utility for patients with cerebrovascular and neurodegenerative diseases.

Related Concept Videos